AudioEye Stops Selling Deadlines and Starts Selling the AI Itself
A record-margin quarter, a $15 million buyback, and a 45% eight-day rip — while the regulatory keywords that anchored three years of calls quietly vanish from the script.
AEYE · Earnings Call · 2026-10-26
The Threat Gets a Product Attached
For at least three straight quarters, analysts have asked AudioEye some version of the same question: what happens when large language models and AI coding tools learn to do digital accessibility themselves? For three quarters the answer was assertion. In August, Kelly Georgevich said “we are not seeing in any impact from competitors coming in” — Kelly Georgevich, Chief Executive Officer · 2026-08-13. This quarter she repeated it: “We haven't seen much in the market, no ... no one can replicate that.” — Kelly Georgevich, Chief Executive Officer · 2026-10-26
What changed in Q3 is that the assertion finally has evidence and a price tag attached. On October 8 the company shipped two products — Agentic Audits and an SDK MCP — both built on AudioEye Intelligence, the dataset management has been waving around for a year: over a million human accessibility reviews across more than 100,000 sites over ten years. The pitch has inverted. Instead of defending against AI coding tools, AudioEye now argues they are the problem, publishing a study in which AI agents instructed to build accessible sites produced ~55 issues per page. And it argues that AI agents need the accessibility tree to transact at all — 31% task completion on the least accessible site, 96% after AudioEye fixes.
This is a company-unique framing. Agentic language is now everywhere across this reporting week — Pegasystems sells agentic workflows, Spotify talks about the agentic age — but nobody else is monetizing remediation of the machine-readable layer of the web. Note, though, that the underlying plumbing is not new: Playwright MCP and the Model Context Protocol were already top-of-transcript keywords back in late 2024. What is new is the commercial wrapper, and Georgevich concedes it is early: “We just released the product a couple of weeks ago ... some of it has to be education on the customer side.” — Kelly Georgevich, Chief Executive Officer · 2026-10-26
The Keywords Management Stopped Saying
The loudest signal on this call is an absence. Through 2025 and into mid-2026, the company's keyword profile was dominated by compliance clocks: Title II, the European Accessibility Act, EAA enforcement, warning letters, and "inflection point." All of those were top-ranked themes as recently as the second quarter. In the Q3 transcript they are essentially gone — replaced by a passing mention of Hawaii's new Act 257 and the European Standards Body adopting WCAG 2.2.
The rhetoric has softened in lockstep. In May, on the EU: “once enforcement happens, all bets are off” — Kelly Georgevich, Chief Executive Officer (CEO) · 2026-05-12. In March: “we are seeing pipeline building nicely, big deals in the pipeline” — David Moradi, CEO · 2026-03-05. This quarter, Europe is reduced to a conditional footnote — enforcement "could move the needle further." Meanwhile the demand engine cited on the call is litigation, not regulation:
We're seeing some of our best lead volume to date still ... Litigation is still growing at record levels. So that's definitely a factor that we're continuing to see. And so regulation is helping, but I think demand overall is growing and that litigation — private litigation — is driving demand as well.
That is a materially different business model story than the one sold to investors for the past three years, and it deserves attention. Regulation is now an option; litigation and AI readiness are the engine.
The Margin Machine, and the Revenue Underneath It
Q3 was, on the numbers, a cost story dressed as a growth story. Revenue rose about 7% to roughly $11 million — the 43rd consecutive record — while cost of revenue fell 19%, producing what CFO Matthew Domeyer called 160% conversion of incremental revenue to gross profit. GAAP gross margin hit 78.8% on the last reported quarter, up 26 points over three years, and adjusted gross margin reached 88%, up more than 550 basis points year over year, credited to AI-driven efficiencies in engineering and service delivery. R&D fell 17% to about 12% of revenue, pushing research spend to roughly a ninth of sales. That flowed to positive GAAP net income of $1 million versus a $0.6 million loss a year ago, and to adjusted EBITDA of $3.9 million at a 35% margin.
Useful context: the operating line is only just crossing zero. The operating margin was -5.6% on the last filed quarter and inflected positive in Q3's GAAP print. Guidance now calls for $13.4–13.6 million of adjusted EBITDA on $43.6–43.8 million of revenue for the year — roughly 50% EBITDA growth on a high-single-digit revenue base. That math works only if the margin gains hold, and Domeyer would not call the step-change temporary: “we expect to be able to maintain those rates, and we'll keep looking for room to expand the margins” — Matthew Domeyer, Chief Financial Officer · 2026-10-26.
The missing piece is top line. Enterprise revenue was roughly flat year over year, a function of deliberately sunsetting nonrecurring revenue; ARR grew 12% to $43.3 million, with enterprise ARR up 10% and partner/marketplace up 14%. Customers rose 6% to about 130,000. The honest growth number is low-double-digit ARR, not the EBITDA line.
Cheap — or Just Cheaper?
The cash turn is real. Litigation expenses fell roughly 50% sequentially, a trend management flagged two quarters ago (“We do expect it to ramp down the second half of 2026” — Kelly Georgevich, Chief Executive Officer · 2026-08-13), with further reduction guided for Q4. That is what unlocks cash generation — Q3 free cash flow of $3.5 million, and a promised ramp into 2027.
Management is deploying it into its own stock: a $15 million repurchase authorization through October 2027, framed as roughly 15% of shares outstanding at current prices. Georgevich's rationale was blunt: “our stock is trading at 6x EBITDA adjusted EBITDA and growing 50% over year. So we do think it's an attractive time to buy” — Kelly Georgevich, Chief Executive Officer · 2026-10-26. She also flagged that revenue has nearly doubled in five years while “our outstanding shares have increased by approximately 10%” — Kelly Georgevich, Chief Executive Officer · 2026-10-26 — a fair governance point from a serial acquirer with a history of using equity.
The tape complicates the bargain. Price-to-revenue sits at 1.7x, down 54% year over year and near the low end of a decade, still 77% below the 2021 peak — yet shares are up 67% in ninety trading days, including a 45% surge in the last eight sessions. Management is buying after a sharp re-rating, and the size of the buyback relative to a $127 million market cap and effective net cash of about -$8 million means it leans on the promised litigation-driven cash flow.
What to Watch
Three tells. First, whether AI readiness converts from a whitepaper into attach-rate revenue — Georgevich declined to quantify uplift, calling it “too early to quantify</i>” — Kelly Georgevich, Chief Executive Officer · 2026-10-26. Second, whether ARR reaccelerates toward the low-to-mid teens in 2027 absent an EU enforcement catalyst, since the compliance narrative has been quietly retired. Third, whether litigation expense keeps falling — it is now the single biggest swing factor between a 6x EBITDA small cap and something that actually compounds.